课题基金 / 基金详情

The molecular mechanism by which FoxO1 regulates islet vascularization and compensative beta cell proliferation

The molecular mechanism by which FoxO1 regulates islet vascularization and compensative beta cell proliferation
FoxO1调节胰岛血管化和代偿性β细胞增殖的分子机制
批准号:
22790843
负责人:
HASHIMOTO Hiromi
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011

项目摘要

项目成果

HASHIMOTO Hiromi的其他基金

相似基金

相关文献

中文摘要
翻译
遗传学研究表明,胰腺中胰岛素/IGF-1信号的消融导致糖尿病。fox01是胰岛素/IGF-1信号的下游转录因子。我们之前报道过fox01单倍功能不足恢复。IRS2基因敲除小鼠的细胞质量和拯救性糖尿病然而,目前尚不清楚胰腺中fox01的失调是否可能是糖尿病的原因。为了验证这一假设,我们在胰腺中产生了特异性过表达构成型活性FoxO1的转基因小鼠(TG)。甘油三酯小鼠的葡萄糖耐量受损,其中一些小鼠确实因葡萄糖含量降低而患上了糖尿病。细胞质量,这与Pdx1和MafA的减少有关。细胞。我们还观察到,由于VEGF-A表达增加,TG小鼠的胰岛血管增生。细胞。我们进行了染色质免疫沉淀(ChIP)实验,结果显示FoxO1与VEGF-A启动子结合。我们还在荧光素酶实验中发现fox01调节VEGF-A的转录。细胞。当fox01被腺病毒过表达时,VEGF-A mRNA水平升高。TC3细胞。尽管严重减少。细胞、血浆胰岛素水平和血糖水平以及葡萄糖耐量都轻微受损。我们认为这是由于TG小鼠中VEGF-A表达增加和胰岛血管性增加所致。我们认为FoxO1在胰腺的糖代谢调控中起重要作用。
英文摘要
Genetic studies revealed that the ablation of insulin/IGF-1 signaling in the pancreas causes diabetes. FoxO1 is a downstream transcription factor of insulin/IGF-1 signaling. We previously reported that FoxO1 haploinsufficiency restored . cell mass and rescued diabetes in IRS2 knockout mice. However, it is still unclear whether FoxO1 dysregulation in the pancreas could be the cause of diabetes. To test this hypothesis, we generated transgenic mice overexpressing constitutively active FoxO1 specifically in the pancreas (TG). TG mice had impaired glucose tolerance and some of them indeed developed diabetes due to the reduction of . cell mass, which is associated with decreased Pdx1 and MafA in . cells. We also observed that TG mice have islet hypervascularities due to increased VEGF-A expression in . cells. We performed chromatin immunoprecipitation (ChIP) assays and showed that FoxO1 binds to the VEGF-A promoter. We also showed in luciferase assays that FoxO1 regulates VEGF-A transcription in . cells. When FoxO1 is over expressed by adenovirus, VEGF-A mRNA level was increased in .TC3 cells. Despite severe reduction of . cells, plasma insulin levels and blood glucose levels as well as glucose tolerance were marginally impaired. We suppose this is due to increased VEGF-A expression and increased islets vascularity in TG mice. We propose that FoxO1 in pancreas plays important roles in the regulation of glucose metabolism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0032249
发表时间: 2012-02-23
期刊: PLOS ONE
影响因子: 3.7
作者: [Kikuchi, Osamu, Kobayashi, Masaki, Kitamura, Tadahiro]
通讯作者: Kitamura, Tadahiro
Cholesterol biosynthesis pathway enhance regulated insulin secretion and secretory granule formation in pancreatic β-cells.
  • 批准号:
    19790392
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $3.83万
  • 财政年份:
    2007
  • 负责人:
    HASHIMOTO Hiromi
  • 依托单位:
国内基金
海外基金
免疫代谢失衡介导辅助生殖治疗外源性激素暴露诱发妊娠期糖尿病的机制研究
  • 批准号:
    ZCLQN26H2603
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    朱汇
  • 依托单位:
肠道微生态驱动的孕早期妊娠期糖尿病预测模型构建及 CDCA-FXR-GLP-1 调控机制研究
  • 批准号:
    ZCLMRY26H2001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    朱波
  • 依托单位:
RANBP2/KIF5B在糖尿病肾脏病肾小球足细胞足突融合中的作用及机制
  • 批准号:
    JCZRQNB202600248
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
厌氧硝酸盐呼吸与柠檬酸代谢在糖尿病患者肺炎克雷伯菌感染中的作用及机制研究
  • 批准号:
    JCZRLH202600064
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: